467
edits
Cardiac Pharmacology: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 328: | Line 328: | ||
!Side Effects (Prevalence %) | !Side Effects (Prevalence %) | ||
|- | |- | ||
!colspan="5"|Anti-hypertensives | |||
|- | |- | ||
|rowspan="2"|Diuretics | |rowspan="2"|Diuretics | ||
| Line 405: | Line 405: | ||
|Nifedipine: 5-20mg 3 times daily | |Nifedipine: 5-20mg 3 times daily | ||
|- | |- | ||
!colspan="5"|Anti-Arrhythmics | |||
|- | |- | ||
|Class I (sodium channel blockers) | |Class I (sodium channel blockers) | ||
| Line 440: | Line 440: | ||
|62.5-125 µg daily | |62.5-125 µg daily | ||
|- | |- | ||
!colspan="5"|Anti-platelet Drugs | |||
|- | |- | ||
|rowspan="7"| | |rowspan="7"| | ||
| Line 472: | Line 472: | ||
|Dyspnoea (13.8%), haemorrhage, bruising; nausea (4.3%), vomiting, diarrhoea (3.7%), hypertension (3.8%), hypotension (3.2%), back pain (3.6%), abdominal pain, dyspepsia, gastritis, dizziness (4.5%), chest pain (3.7%), headache (6.5%), cough (4.9%), rash, pruritus, fatigue (3.2%), constipation, arrhythmias including atrial fibrillation (4.2%), paraesthesia, confusion, hyperuricaemia, raised serum creatinine (7.4%), vertigo.<cite>Esc37</cite><cite>Esc38</cite> | |Dyspnoea (13.8%), haemorrhage, bruising; nausea (4.3%), vomiting, diarrhoea (3.7%), hypertension (3.8%), hypotension (3.2%), back pain (3.6%), abdominal pain, dyspepsia, gastritis, dizziness (4.5%), chest pain (3.7%), headache (6.5%), cough (4.9%), rash, pruritus, fatigue (3.2%), constipation, arrhythmias including atrial fibrillation (4.2%), paraesthesia, confusion, hyperuricaemia, raised serum creatinine (7.4%), vertigo.<cite>Esc37</cite><cite>Esc38</cite> | ||
|- | |- | ||
!colspan="5"|Vitamin K Antagonists | |||
|- | |- | ||
| | | | ||
| Line 486: | Line 486: | ||
|valign="top"|Haemorrhage, nausea, vomiting, diarrhoea, jaundice, hepatic dysfunction, pancreatitis, pyrexia, alopecia, purpura, rash, ‘purple toes’, skin necrosis (increased risk in patients with protein C or protein S deficiency) | |valign="top"|Haemorrhage, nausea, vomiting, diarrhoea, jaundice, hepatic dysfunction, pancreatitis, pyrexia, alopecia, purpura, rash, ‘purple toes’, skin necrosis (increased risk in patients with protein C or protein S deficiency) | ||
|- | |- | ||
!colspan="5"|Lipid-Lowering Drugs | |||
|- | |- | ||
|rowspan="3"|Statins | |rowspan="3"|Statins | ||